mAbs
Landes Bioscience · United States · Est. 1967
Aims & Scope✦ Inferred from recent articles
This journal focuses on the development, engineering, and characterization of monoclonal antibodies (mAbs) and antibody fragments for therapeutic and research applications. Articles cover methods for antibody production and purification, strategies for generating antibodies against challenging targets, and the assessment of antibody developability, stability, and pharmacokinetics. Additionally, the journal explores antibody engineering for enhanced efficacy, reduced immunogenicity, and targeted delivery, including bispecific antibodies and antibody-drug conjugates. Glycosylation, protein-protein interactions, and formulation strategies influencing antibody behavior are also key areas of investigation.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref